Re: Right of first refusal
in response to
by
posted on
Mar 04, 2019 01:29PM
Koo - Yes, I do agree on that but I am saying that with BoM success, a US license on Apabetalone should be worth more than $1 billion. The US market is a huge part of the market and at higher margin than many other areas. I am saying that if it isn't worth more than $1 billion, we will have trouble getting the share price, we are hoping for.